LA HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
NantWorks, billionaire Patrick Soon-Shiong’s Culver City holding company, has inked a deal with San Diego biopharmaceutical firm Sorrento Therapeutics Inc. to develop cancer and auto-immune disease treatments.
A growing number of union members at the six Daughters of Charity Health System hospitals in California have gone against their own union leadership and signed petitions in support of the sale of the hospitals to Prime Healthcare Services of Ontario, the hospital chain said.
Amgen Inc. has released detailed positive results from a study on cancer treatment Kyprolis, a key drug for the biopharmaceutical company that disappointed investors with earlier trial results.
NantHealth, the health care technology division of billionaire Patrick Soon-Shiong’s Culver City holding company NantWorks, has revealed the first product of its collaboration with smartphone-maker BlackBerry: a secure clinical genome browser that gives doctors access to patients’ genetic data on the BlackBerry Passport smartphone.
Every week the Los Angeles Business Journal asks readers their views on a variety of business and economic issues. A running tally is available on the site and later will be published in the Commentary section of our print edition. Our latest poll is available on the bottom right column of our home page.
A physician’s assistant was sentenced Monday to three years in federal prison for defrauding Medicare out of millions of dollars by signing fraudulent prescriptions and other medical documents while working at two separate medical clinics in the Los Angeles area.
Amgen Inc. announced on Monday it has ended two clinical studies on an experimental cancer drug after a preliminary review showed increased deaths among one group of patients.
Shares of Second Sight Medical Products Inc. – the latest Alfred Mann company to go public – more than doubled Wednesday in its initial public offering.
CytRx Corp. shares fell 9 percent Tuesday after the company announced the U.S. Food and Drug Administration had placed a hold on enrolling new patients in clinical trials of its experimental cancer drug following the death of a patient.
Second Sight Medical Products Inc., a maker of an artificial retina for blind patients, delayed its planned $30 million IPO until Wednesday.
Second Sight Medical Products Inc., a maker of an artificial retina for blind patients, plans to launch a $30 million initial public offering on Tuesday.
MannKind Corp. posted narrow third-quarter losses on Monday as the company winds down its research operations and prepares to start selling its Afrezza brand inhalable insulin.
An owner of Los Angeles home health agency Fifth Avenue Home Health has been indicted for allegedly aiding in a $33 million scheme to defraud Medicare, the U.S. Justice Department announced Thursday.
Amgen posted third-quarter earnings Monday that beat Wall Street estimates, as the company reported strong drug sales and benefited from cost-cutting once restructuring costs were excluded.
USC’s medical system announced on Wednesday that it will partner with Surgical Care Affiliates Inc. to jointly manage surgery centers in the Los Angeles region, starting with one in Glendale.